Last reviewed · How we verify
NCT07031557: POI
Pregnancy and Lactation- Associated Osteoporosis
trial testing EchoStation Implementing REMS Technology in Osteoporosis and Fracture Risk in Pregnant Women in 1,230 participants. Participants enrolled and being followed up; not accepting new ones.
8 September 2025
Quick facts
| Lead sponsor | Parma University Hospital |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 1,230 |
| Start date | 9 September 2024 |
| Primary completion | 8 September 2025 |
| Estimated completion | 8 September 2026 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- EchoStation Implementing REMS Technology
- Nutritional and Fracture Risk Assessment Questionnaires
Conditions studied
- Osteoporosis and Fracture Risk in Pregnant Women — all drugs for Osteoporosis and Fracture Risk in Pregnant Women →
Sponsor
Parma University Hospital
Who can join
Adults 18 to 45, female only, with Osteoporosis and Fracture Risk in Pregnant Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pregnancy-Associated Osteoporosis is a condition characterized by loss of bone mass and fragility fractures during pregnancy or breastfeeding, often due to the increased calcium request from fetus. It typically manifests from the third trimester of pregnancy or in the early months of breastfeeding. Therefore, early diagnosis is crucial to prevent fractures and vertebral collapses. The study aims to monitor bone mineral density (BMD) and fracture risk in pregnant and breastfeeding women using: 1. Questionnaires on calcium intake, dietary habits (Predimed), and fracture risk (AFEF); 2. Ultrasound densitometry (REMS) in the first and third trimester of pregnancy and during breastfeeding.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07031557
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Parma University Hospital trials
Trials by the same sponsor.
- NCT05793970 — IL6 on Umbilical Cord (Evaluation of IL-6 Levels on Umbilical Cord) · unknown
- NCT04829032 — GOODBYE HARTMANN TRIAL: 100 YEARS OF HARTMANN'S PROCEDURE · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07031557 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Parma University Hospital
- Last refreshed: 5 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07031557.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing